CLDN4 and lung adenocarcinoma: In this present study, our findings indicate that the downregulation of CGN and FOXO1 leads to malignant cell proliferation, cell migration, and altered cell metabolism by upregulating CLDN-2 or CLDN-4 through the MAPK/AMPK pathways in human lung adenocarcinoma A549 cells (Figure 7).